Open AccessAdministration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease
Author(s) -
Diana F. Florescu,
André C. Kalil,
Angela Hewlett,
Amy J. Schuh,
Ute Ströher,
Timothy M. Uyeki,
Philip W. Smith
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ395
Subject(s) - ebola virus , convalescent plasma , medicine , disease , intensive care medicine , virus , randomized controlled trial , virology , convalescence , ebolavirus , covid-19 , infectious disease (medical specialty)
From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom